Cardiac Dysfunction in Children and Young Adults Treated With MEK Inhibitors: A Retrospective, Single-Center Study

JACC CardioOncol. 2024 Aug 6;6(5):794-796. doi: 10.1016/j.jaccao.2024.07.004. eCollection 2024 Oct.

Jonathan D Bender^{1

2}, Natasha Pillay-Smiley^{1

2}, Garick D Hill^{1

3}, Peter de Blank^{1

2}, Trent R Hummel^{1

2}, Brian D Weiss^{1

2}, Ashish Kumar^{1

4}, Huaiyu Zang³, Nicholas J Ollberding^{1

5}, Thomas D Ryan^{1

3}

¹ Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
² Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
³ Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
⁴ Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
⁵ Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

No abstract available

Keywords: cardiomyopathy; diagnosis; echocardiography; risk prediction; screening; treatment.